Edition:
India

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

95.19USD
1:30am IST
Change (% chg)

$-1.72 (-1.77%)
Prev Close
$96.91
Open
$96.49
Day's High
$97.06
Day's Low
$94.63
Volume
196,559
Avg. Vol
149,081
52-wk High
$102.75
52-wk Low
$46.91

Chart for

About

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximatel... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $3,415.65
Shares Outstanding(Mil.): 58.06
Dividend: --
Yield (%): --

Financials

BRIEF-Insulet Reports Q1 Loss Per Share $0.11

* INSULET REPORTS FIRST QUARTER 2018 REVENUE OF $123.6 MILLION, UP 21% YEAR-OVER-YEAR, AND GROSS MARGIN OF 61.4%, UP 300 BASIS POINTS, EXCEEDING EXPECTATIONS

04 May 2018

BRIEF-Insulet Establishes Two Significant Commercial Partnerships To Support Its European Expansion

* INSULET ESTABLISHES TWO SIGNIFICANT COMMERCIAL PARTNERSHIPS TO SUPPORT ITS EUROPEAN EXPANSION

02 May 2018

BRIEF-Insulet Corp Says CEO's 2017 Total Compensation Was $8.2 Mln Vs $6 Mln In 2016

* INSULET CORP SAYS CEO PATRICK J. SULLIVAN'S 2017 TOTAL COMPENSATION WAS $8.2 MLN VS $6 MLN IN 2016 – SEC FILING‍​‍​ Source text: (https://bit.ly/2EsXkmY) Further company coverage:

06 Apr 2018

BRIEF-Insulet Corp Posts Q4 Loss Per Share $0.12

* INSULET REPORTS FOURTH QUARTER REVENUE OF $130.5 MILLION, UP 26%, AND GROSS MARGIN UP 210 BASIS POINTS, EXCEEDING EXPECTATIONS

22 Feb 2018

BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp

* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT

09 Jan 2018

Competitors

Earnings vs. Estimates